• CARMIL Membrane Binding Controls Actin Assembly

  2026-08-12

  The reference study identifies the CARMIL membrane-binding domain as an active regulator of capping protein rather than a passive membrane tether. Its results support a dynamic model in which CARMIL recruits capping protein and actin assembly machinery to membranes, then disengages after capping protein binding to promote uncapping and soluble capping-protein activity.

• Amyloid Beta-Peptide (1-40): Research Workflows

  2026-08-12

  Build reproducible aggregation, membrane-interaction, and neurotoxicity assays with a defined human Aβ40 sequence. This guide translates calcium-sensitive surface measurements into practical workflows for Alzheimer’s disease research peptide applications, including controls, optimization, and troubleshooting.

• Pseudo-UTP for Modified mRNA Synthesis

  2026-08-11

  Pseudo-UTP is a pseudouridine-containing UTP substitute for in vitro transcription and mRNA synthesis with pseudouridine modification. Its use can support RNA stability enhancement, translation, and reduced innate immune activation, but outcomes depend on transcript design, polymerase conditions, purification, and cell context.

• 1-myristoylglycerophosphocholine Assay Guide

  2026-08-11

  Build defined lysophospholipid experiments for fibroblast activation, epithelial lipid transfer, and smooth muscle function. This workflow combines concentration-response design, lipidomics-aware controls, and practical handling guidance for 14:0 Lyso-PC.

• Reelin–SFK Signaling in Ketamine Antidepressant Action

  2026-08-10

  The reference study identifies intact Reelin–Apoer2–Src family kinase signaling as a permissive requirement for ketamine-induced hippocampal synaptic plasticity and antidepressant-like behavioral effects in mice. Its genetic and pharmacological experiments suggest that impaired baseline NMDA receptor function, rather than a simple failure of ketamine to alter downstream phosphorylation, may contribute to nonresponsiveness.

• M344: Reliable HDAC Assay Design

  2026-08-09

  This scenario-driven guide explains how M344 (SKU A4105) can support interpretable viability, proliferation, differentiation, and apoptosis workflows. It connects documented potency and handling data with practical decisions about dosing, solvent control, assay compatibility, and vendor reliability.

• Dihydroethidium (DHE): Superoxide Assay Guide

  2026-08-08

  Dihydroethidium, also called hydroethidine, is a cell-permeable fluorescent probe used for relative intracellular superoxide measurement. Reliable interpretation requires separating superoxide-derived 2-hydroxyethidium from nonspecific ethidium formation and validating red fluorescence with appropriate controls.

• MK-2206 dihydrochloride: Assay Guide

  2026-08-07

  A scenario-driven guide to using MK-2206 dihydrochloride (SKU A3010) in viability, proliferation, apoptosis, and PI3K/Akt/mTOR pathway experiments. It covers dose interpretation, solvent compatibility, orthogonal readouts, and practical vendor-selection criteria for more defensible laboratory decisions.

• Moesin as a Biomarker of Sepsis-Induced Endothelial Injury

  2026-08-07

  This study establishes moesin (MSN) as a novel serum biomarker for endothelial injury severity in sepsis, showing its mechanistic role in vascular permeability and inflammation. The findings provide new avenues for evaluating sepsis progression and targeting endothelial dysfunction in translational research.

• Z-VAD-FMK in Translational Apoptosis Research: Mechanisms &

  2026-08-06

  This thought-leadership article explores how Z-VAD-FMK, an irreversible pan-caspase inhibitor, advances translational apoptosis research. It provides mechanistic context, practical workflow strategies, and cross-compares emerging evidence from cancer models to inform pathway dissection and therapeutic development.

• Phosbind Biotin: Dinuclear Metal Complex for Phosphorylation

  2026-08-06

  Phosbind Biotin leverages dinuclear metal complex phosphate binding to offer sequence-independent, highly sensitive detection of phosphorylated proteins—streamlining Western Blot workflows and empowering advanced signal transduction research. Its robust performance as a phospho-specific antibody alternative unlocks new experimental flexibility across plant and biomedical studies.

• RNA Pol II Degradation Triggers Apoptosis Beyond Transcripti

  2026-08-05

  Harper et al. reveal that cell death following RNA Pol II inhibition is not due to passive loss of transcription but is actively signaled by the degradation of hypophosphorylated RNA Pol IIA, engaging a regulated apoptotic pathway. These findings challenge longstanding assumptions in DNA damage response research and inform new strategies for targeting transcriptional machinery in cancer biology.

• 3X (DYKDDDDK) Peptide: Mechanistic Insights and Translationa

  2026-08-05

  Explore how the 3X (DYKDDDDK) Peptide advances affinity purification, structural biology, and translational research strategy—integrating mechanistic, experimental, and clinical perspectives with evidence from cutting-edge lipid transport studies.

• T-5224 (C-Fos/AP-1 Inhibitor): Beyond Inflammation to Ferrop

  2026-08-04

  Discover how T-5224, a selective C-Fos/AP-1 inhibitor, advances research from arthritis and inflammation to ferroptosis and cancer cell death. This article reveals new mechanistic insights and practical guidance for leveraging T-5224 in complex disease models.

• iTBS Enhances Motor Function and Reduces Pathology in SCA3 M

  2026-08-04

  This study demonstrates that intermittent theta-burst stimulation (iTBS) significantly improves motor coordination and mitigates neuroinflammation and protein aggregation in a mouse model of spinocerebellar ataxia type 3 (SCA3/MJD). The findings highlight iTBS as a promising noninvasive intervention for modifying disease pathology and functional outcomes in SCA3.

8101 records 4/541 page Previous Next 12345 下5页 Last page